Mcf Advisors LLC Amgen Inc Transaction History

Mcf Advisors LLC

$1.42 Billion
Q3 2024

A detailed history of Mcf Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Mcf Advisors LLC holds 4,473 shares of AMGN stock, worth $1.32 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

4,473

Previous 4,511 0.84%

Holding current value

$1.32 Million

Previous $1.41 Million 2.27%

% of portfolio

0.1%

Previous 0.11%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$309.38 - $337.38 $11,756 - $12,820	-38 Reduced 0.84%	4,473 $1.44 Million
Q2 2024 Aug 05, 2024	BUY	$262.75 - $319.31 $53,338 - $64,819	203 Added 4.71%	4,511 $1.41 Million
Q1 2024 Apr 16, 2024	BUY	$268.87 - $324.56 $39,255 - $47,385	146 Added 3.51%	4,308 $1.22 Million
Q4 2023 Feb 01, 2024	BUY	$255.7 - $288.46 $17,387 - $19,615	68 Added 1.66%	4,162 $1.2 Million
Q3 2023 Oct 19, 2023	BUY	$218.65 - $271.46 $15,305 - $19,002	70 Added 1.74%	4,094 $1.1 Million
Q2 2023 Jul 24, 2023	BUY	$214.27 - $253.37 $4,499 - $5,320	21 Added 0.52%	4,024 $893,000
Q1 2023 Apr 18, 2023	SELL	$225.79 - $275.2 $47,415 - $57,792	-210 Reduced 4.98%	4,003 $967,000
Q4 2022 Jan 31, 2023	BUY	$229.03 - $291.01 $112,911 - $143,467	493 Added 13.25%	4,213 $1.11 Million
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $164,753 - $185,812	734 Added 24.58%	3,720 $839,000
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $3,460 - $3,851	-15 Reduced 0.5%	2,986 $726,000
Q1 2022 May 05, 2022	BUY	$219.27 - $242.57 $658,029 - $727,952	3,001 New	3,001 $725,000
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $493,023 - $564,220	-2,479 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $143,919 - $168,618	678 Added 37.65%	2,479 $527,000
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $101,140 - $112,207	433 Added 31.65%	1,801 $439,000
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $37,502 - $43,703	169 Added 14.1%	1,368 $340,000
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $18,068 - $20,093	77 Added 6.86%	1,199 $305,000
Q2 2018 Jul 20, 2018	SELL	$166.05 - $186.51 $12,785 - $14,361	-77 Reduced 6.42%	1,122 $207,000
Q3 2017 Oct 30, 2017	BUY	$167.29 - $191.0 $200,580 - $229,009	1,199	1,199 $224,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.

Account